Late referral of patients with chronic kidney disease is associated with increased morbidity and mortality, but the contribution of center-to-center and geographic variability of pre-ESRD nephrology care to mortality of patients with ESRD is unknown. We evaluated the pre-ESRD care of > 30,000 incident hemodialysis patients, 5088 (17.8%) of whom died during follow-up (median 365 d). Approximatel...

The capacity of risk prediction to guide management of CKD in underserved health settings is unknown. We conducted a retrospective cohort study of 28,779 adults with nondialysis-requiring CKD who received health care in two large safety net health systems during 1996-2009 and were followed for ESRD through September of 2011. We developed and evaluated the performance of ESRD risk prediction mod...

BACKGROUND AND OBJECTIVES CKD and ESRD are growing burdens. It is unclear whether these conditions affect pulmonary embolism (PE) risk, given that they affect both procoagulant and anticoagulant factors. This study examined the frequency and associated outcomes of PE in CKD and ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS The Healthcare Cost and Utilization Project's Nationwide Inpatie...

BACKGROUND AND OBJECTIVES Frequent medical encounters in patients with ESRD on dialysis may allow early detection of malignancies despite low rates of cancer screening in this population. It is therefore unclear whether dialysis patients are disadvantaged in terms of cancer diagnosis. This study compared stage at diagnosis of cancer in a population-based sample of patients with ESRD versus the ...

OBJECTIVE The aim of this study was to determine 30-day mortality and 6-month functional recovery rates in spontaneous intracerebral hemorrhage (S-ICH) patients undergoing hemodialysis treatment for end-stage renal disease (ESRD), and to compare the outcomes of these patients and S-ICH patients without ESRD. METHODS The medical records of 1943 S-ICH patients from January 2000 to December 2011...

BACKGROUND The Reduction of Endpoints in NIDDM [non-insulin-dependent diabetes mellitus] with the Angiotensin II Antagonist Losartan (RENAAL) study demonstrated the renoprotective effects of losartan in patients with nephropathy from type 2 diabetes. OBJECTIVE To perform an economic evaluation of the costs associated with end-stage renal disease (ESRD) from a Canadian public health perspectiv...

End stage renal disease (ESRD) has been reported to be an important risk factor for systemic vascular disease. Retinal vein occlusion (RVO) is closely related with cardiovascular diseases; however, its association with ESRD had not been reported. The aim of the study was to investigate whether ESRD is a risk factor for RVO, including central retinal vein occlusion (CRVO) and branch retinal vein...

The SARS-CoV-2 pandemic has been associated with a drop in diagnoses of several diseases 2020, including cancers. In this letter addressed to the editor, Groupement des Néphrologues Francophones de Belgique (GNFB), assessed whether there was similar effect concerning end-stage renal disease (ESRD).
 Data patients ESRD form 25 26 centers constituting GNFB register were collected. conclusion...

Kidney transplant anesthesia can be a mentally challenging yet rewarding aspect of the anesthesiologist’s job. End stage renal disease (ESRD) patients tend to have a medical history that leads to very complex physiology. In this article we will review the pathophysiology of ESRD, the effects of ESRD on other body systems, and how it effects the perioperative management of the ESRD patient.